Rational Truncation of an RNA Aptamer to Prostate-Specific Membrane Antigen Using Computational Structural Modeling

In vitro selection of RNA molecules that bind specific ligands

Ellington, A. D., & Szostak, J. W. (1990) · Nature · doi:10.1038/346818a0 · Cited by 9,845 · see citing works

The Amber biomolecular simulation programs

Case, D. A., Cheatham, T. E., Darden, T., Gohlke, H., Luo, R., Merz, K. M., Onufriev, A., Simmerling, C., Wang, B., & Woods, R. J. (2005) · Journal of Computational Chemistry · doi:10.1002/jcc.20290 · Cited by 9,535 · see citing works

Pegaptanib for neovascular age-related macular degeneration

Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337 · see citing works

Aptamers as therapeutics

Keefe, A. D., Pai, S., & Ellington, A. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3141 · Cited by 2,289 · see citing works

Untitled work

(1997) · PubMed · Cited by 1,541 · see citing works

VARNA: Interactive drawing and editing of the RNA secondary structure

Darty, K., Denise, A., & Ponty, Y. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp250 · Cited by 1,375 · see citing works

Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras

McNamara, J. O., Andrechek, E. R., Wang, Y., Viles, K. D., Rempel, R. E., Gilboa, E., Sullenger, B. A., & Giangrande, P. H. (2006) · Nature Biotechnology · doi:10.1038/nbt1223 · Cited by 1,005 · see citing works

Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA–PEG nanoparticles

Dhar, S., Gu, F., Langer, R., Farokhzad, O. C., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809154105 · Cited by 994 · see citing works

Nanoparticle-Aptamer Bioconjugates

Farokhzad, O. C., Jon, S., Khademhosseini, A., Tran, T.-N., LaVan, D. A., & Langer, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2550 · Cited by 897 · see citing works

2′-Fluoropyrimidine RNA-based Aptamers to the 165-Amino Acid Form of Vascular Endothelial Growth Factor (VEGF165)

Ruckman, J., Green, L. S., Beeson, J., Waugh, S. M., Gillette, W. L., Henninger, D. D., Claesson, L., & Janjić, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20556 · Cited by 744 · see citing works

Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers

Gu, F., Zhang, L., Teply, B. A., Mann, N., Wang, A. Z., Radovic‐Moreno, A. F., Langer, R., & Farokhzad, O. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711714105 · Cited by 714 · see citing works

An Aptamer–Doxorubicin Physical Conjugate as a Novel Targeted Drug‐Delivery Platform

Bagalkot, V., Farokhzad, O. C., Langer, R., & Jon, S. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200602251 · Cited by 614 · see citing works

An RNA motif that binds ATP

Sassanfar, M., & Szostak, J. W. (1993) · Nature · doi:10.1038/364550a0 · Cited by 593 · see citing works

Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors

Dassie, J. P., Liu, X., Thomas, G. S., Whitaker, R. M., Thiel, K. W., Stockdale, K. R., Meyerholz, D. K., McCaffrey, A. P., McNamara, J. O., & Giangrande, P. H. (2009) · Nature Biotechnology · doi:10.1038/nbt.1560 · Cited by 591 · see citing works

Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen.

Lupold, S. E., Hicke, B. J., Lin, Y. H., & Coffey, D. S. (2002) · PubMed · Cited by 564 · see citing works

Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo

Dhar, S., Kolishetti, N., Lippard, S. J., & Farokhzad, O. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011379108 · Cited by 513 · see citing works

RNA aptamers as reversible antagonists of coagulation factor IXa

Rusconi, C. P., Scardino, E., Layzer, J. M., Pitoc, G. A., Ortel, T. L., Monroe, D. M., & Sullenger, B. A. (2002) · Nature · doi:10.1038/nature00963 · Cited by 512 · see citing works

Aptamer mediated siRNA delivery

Chu, T. C. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl388 · Cited by 447 · see citing works

A double-filter method for nitrocellulose-filter binding: application to protein-nucleic acid interactions.

Wong, I., & Lohman, T. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5428 · Cited by 390 · see citing works

Tumor targeting by an aptamer.

Hicke, B. J., Stephens, A. W., Gould, T. A., Chang, Y.-F., Lynott, C. K., Heil, J., Borkowski, S., Hilger, C. S., Cook, G., Warren, S., et al. (2006) · PubMed · Cited by 384 · see citing works

Reversible Cell‐Specific Drug Delivery with Aptamer‐Functionalized Liposomes

Cao, Z. C., Tong, R., Mishra, A., Xu, W., Wong, G. C. L., Cheng, J., & Lu, Y. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200901452 · Cited by 372 · see citing works

[11] Predicting thermodynamic properties of RNA

Serra, M. J., & Turner, D. H. (1995) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(95)59047-1 · Cited by 364 · see citing works

Direct In Vitro Selection of a 2′-O-Methyl Aptamer to VEGF

Burmeister, P. E., Lewis, S. D., Silva, R. F., Preiss, J. R., Horwitz, L. R., Pendergrast, P. S., McCauley, T. G., Kurz, J. C., Epstein, D. M., Wilson, C., et al. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.10.017 · Cited by 346 · see citing works

An iterative knowledge‐based scoring function for protein–protein recognition

Huang, S., & Zou, X. (2008) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21949 · Cited by 336 · see citing works

Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice

McNamara, J. O., Kolonias, D. S., Pastor, F., Mittler, R. S., Chen, L., Giangrande, P. H., Sullenger, B. A., & Gilboa, E. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33365 · Cited by 311 · see citing works

Novel Dual Inhibitory Function Aptamer–siRNA Delivery System for HIV-1 Therapy

Zhou, J., Li, H., Li, S. X., ZAIA, J. A., & Rossi, J. J. (2008) · Molecular Therapy · doi:10.1038/mt.2008.92 · Cited by 301 · see citing works

Pharmacokinetics and Biodistribution of Novel Aptamer Compositions

Healy, J. M., Lewis, S. D., Kurz, M., Boomer, R. M., Thompson, K. M., Wilson, C., & McCauley, T. G. (2004) · Pharmaceutical Research · doi:10.1007/s11095-004-7676-4 · Cited by 300 · see citing works

RNA Folding: Conformational Statistics, Folding Kinetics, and Ion Electrostatics

Chen, S. (2008) · Annual Review of Biophysics · doi:10.1146/annurev.biophys.37.032807.125957 · Cited by 299 · see citing works

Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay

Pastor, F., Kolonias, D. S., Giangrande, P. H., & Gilboa, E. (2010) · Nature · doi:10.1038/nature08999 · Cited by 297 · see citing works

Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase

Davis, M. I., Bennett, M. J., Thomas, L. M., & Bjorkman, P. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502101102 · Cited by 296 · see citing works

Year 2 Efficacy Results of 2 Randomized Controlled Clinical Trials of Pegaptanib for Neovascular Age-Related Macular Degeneration

⁎ (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.02.064 · Cited by 291 · see citing works

First-in-Human Evaluation of Anti–von Willebrand Factor Therapeutic Aptamer ARC1779 in Healthy Volunteers

Gilbert, J. C., DeFeo-Fraulini, T., Hutabarat, R. M., Horvath, C. J., Merlino, P. G., Marsh, H. N., Healy, J. M., BouFakhreddine, S., Holohan, T. V., & Schaub, R. G. (2007) · Circulation · doi:10.1161/circulationaha.107.724864 · Cited by 286 · see citing works

Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells

Zhou, J.-H., Swiderski, P., Li, H.-T., Zhang, J., Neff, C., Akkina, R., & Rossi, J. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp185 · Cited by 284 · see citing works

An Aptamer-siRNA Chimera Suppresses HIV-1 Viral Loads and Protects from Helper CD4 + T Cell Decline in Humanized Mice

Neff, C. P., Zhou, J., Remling‐Mulder, L., Kuruvilla, J., Zhang, J., Li, H., Smith, D. D., Swiderski, P. M., Rossi, J. J., & Akkina, R. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001581 · Cited by 259 · see citing works

Novel Approach to Specific Growth Factor Inhibition in Vivo

Floege, J., Ostendorf, T., Janssen, U., Burg, M., Radeke, H. H., Vargeese, C., Gill, S. C., Green, L. S., & Janjić, N. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65263-7 · Cited by 233 · see citing works

First-in-Human Experience of an Antidote-Controlled Anticoagulant Using RNA Aptamer Technology

Dyke, C. K., Steinhubl, S. R., Kleiman, N. S., Cannon, R. O., Aberle, L. G., Lin, M. J., Myles, S. K., Melloni, C., Harrington, R. A., Alexander, J. H., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.668434 · Cited by 222 · see citing works

Potent 2'-Amino-2'-deoxypyrimidine RNA Inhibitors of Basic Fibroblast Growth Factor

Jellinek, D., Green, L. S., Bell, C., Lynott, C. K., Gill, N., Vargeese, C., Kirschenheuter, G. P., McGee, D. P. C., & Abesinghe, P. (1995) · Biochemistry · doi:10.1021/bi00036a009 · Cited by 213 · see citing works

Prostate-Specific Membrane Antigen Targeted Imaging and Therapy of Prostate Cancer Using a PSMA Inhibitor as a Homing Ligand

Kularatne, S. A., Wang, K., Santhapuram, H. K. R., & Low, P. S. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900069d · Cited by 192 · see citing works

Oligo- and poly-nucleotides: 50 years of chemical synthesis

Reese, C. B. (2005) · Organic & Biomolecular Chemistry · doi:10.1039/b510458k · Cited by 191 · see citing works

Modified RNA sequence pools forin vitroselection

Lin, Y. H., Qiu, Q., Gill, S. C., & Jayasena, S. D. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.24.5229 · Cited by 182 · see citing works

Cloning, expression, genomic localization, and enzymatic activities of the mouse homolog of prostate-specific membrane antigen/NAALADase/folate hydrolase

Bacich, D. J., Pinto, J. T., Tong, W. P., & Heston, W. D. W. (2001) · Mammalian Genome · doi:10.1007/s003350010240 · Cited by 178 · see citing works

Therapeutic Applications of DNA and RNA Aptamers

Thiel, K. W., & Giangrande, P. H. (2009) · Oligonucleotides · doi:10.1089/oli.2009.0199 · Cited by 173 · see citing works

Expression of prostate‐specific membrane antigen (PSMA), increases cell folate uptake and proliferation and suggests a novel role for PSMA in the uptake of the non‐polyglutamated folate, folic acid

Yao, V., Berkman, C. E., Choi, J. K., O’Keefe, D. S., & Bacich, D. J. (2009) · The Prostate · doi:10.1002/pros.21065 · Cited by 169 · see citing works

Detection and analysis of ?-catenin mutations in prostate cancer

Chesire, D. R., Ewing, C. M., Sauvageot, J., Bova, G. S., & Isaacs, W. B. (2000) · The Prostate · doi:10.1002/1097-0045(20001201)45:4 · Cited by 168 · see citing works

Physics-Based De Novo Prediction of RNA 3D Structures

Cao, S., & Chen, S. (2011) · The Journal of Physical Chemistry B · doi:10.1021/jp112059y · Cited by 164 · see citing works

AS-1411, a guanosine-rich oligonucleotide aptamer targeting nucleolin for the potential treatment of cancer, including acute myeloid leukemia.

Mongélard, F., & Bouvet, P. (2010) · PubMed · Cited by 163 · see citing works

Anti‐VEGF Aptamer (Pegaptanib) Therapy for Ocular Vascular Diseases

Ng, E. W. M., & Adamis, A. P. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1348.062 · Cited by 161 · see citing works

Efficient synthesis of nucleic acids heavily modified with non- canonical ribose 2'-groups using a mutantT7 RNA polymerase (RNAP)

Padilla, R. M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.6.1561 · Cited by 154 · see citing works

RNA Secondary Structure Prediction

Mathews, D. H., Turner, D. H., & Zuker, M. (2007) · Current Protocols in Nucleic Acid Chemistry · doi:10.1002/0471142700.nc1102s28 · Cited by 153 · see citing works

Derivation of RNA aptamer inhibitors of human complement C5

Biesecker, G., Dihel, L., Enney, K., & Bendele, R. A. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(99)00020-x · Cited by 152 · see citing works

Predicting RNA folding thermodynamics with a reduced chain representation model

Cao, S., & Chen, S. (2005) · RNA · doi:10.1261/rna.2109105 · Cited by 139 · see citing works

RNA Secondary Structure Analysis Using RNAstructure

Mathews, D. H. (2006) · Current Protocols in Bioinformatics · doi:10.1002/0471250953.bi1206s13 · Cited by 132 · see citing works

Exploring the sequence space of a DNA aptamer using microarrays

Katilius, E., Flores, C. L., & Woodbury, N. W. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm922 · Cited by 119 · see citing works

The Prostate Specific Membrane Antigen Regulates the Expression of IL-6 and CCL5 in Prostate Tumour Cells by Activating the MAPK Pathways1

Colombatti, M., Grasso, S., Porzia, A., Fracasso, G., Scupoli, M. T., Cingarlini, S., Poffe, O., Naim, H. Y., Heine, M., Tridente, G., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004608 · Cited by 114 · see citing works

Mechanism of Ribose 2‘-Group Discrimination by an RNA Polymerase

Huang, Y., Eckstein, F., Padilla, R. M., & Sousa, R. (1997) · Biochemistry · doi:10.1021/bi962674l · Cited by 104 · see citing works

MDockPP: A hierarchical approach for protein‐protein docking and its application to CAPRI rounds 15–19

Huang, S., & Zou, X. (2010) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22797 · Cited by 83 · see citing works

Structural probing and damage selection of citrullineand arginine-specific RNA aptamers identify base positions required for binding

Burgstaller, P., Kochoyan, M., & Famulok, M. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.23.4769 · Cited by 82 · see citing works

Dependence of aptamer activity on opposed terminal extensions: improvement of light-regulation efficiency

Buff, M. C. R., Schäfer, F., Wulffen, B., Müller, J., Pötzsch, B., Heckel, A., & Mayer, G. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp1148 · Cited by 81 · see citing works

Post-SELEX Chemical Optimization of a Trypanosome-Specific RNA Aptamer

Göringer, H. U., Adler, A., Forster, N., & Homann, M. (2008) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620708783398331 · Cited by 80 · see citing works

Anti-L-Selectin Aptamers: Binding Characteristics, Pharmacokinetic Parameters, and Activity Against an Intravascular Target In Vivo

Watson, S. R., Chang, Y.-F., O'Connell, D., WEIGAND, L., Ringquist, S., & Parma, D. H. (2000) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.2000.10.63 · Cited by 79 · see citing works

2´-Deoxy Purine, 2´-O-Methyl Pyrimidine (dRmY) Aptamers as Candidate Therapeutics

Burmeister, P. E., Wang, C., Killough, J. R., Lewis, S. D., Horwitz, L. R., Ferguson, A., Thompson, K. M., Pendergrast, P. S., McCauley, T. G., Kurz, M., et al. (2006) · Oligonucleotides · doi:10.1089/oli.2006.16.337 · Cited by 65 · see citing works

Aptamers as a model for functional evaluation of LNA and 2′-amino LNA

Hernández, F. J., Kalra, N., Wengel, J., & Vester, B. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.10.039 · Cited by 60 · see citing works

Affinity hydrogels for controlled protein release using nucleic acid aptamers and complementary oligonucleotides

Soontornworajit, B., Zhou, J., Snipes, M. P., Battig, M. R., & Wang, Y. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.074 · Cited by 59 · see citing works

Generation of a Baculovirus Recombinant Prostate-Specific Membrane Antigen and Its Use in the Development of a Novel Protein Biochip Quantitative Immunoassay

Xiao, Z., Jiang, X., Beckett, M. L., & Wright, G. L. (2000) · Protein Expression and Purification · doi:10.1006/prep.2000.1222 · Cited by 52 · see citing works

Comprehensive Chemical Modification Interference and Nucleotide Substitution Analysis of an RNA Pseudoknot Inhibitor to HIV-1 Reverse Transcrip tase

Green, L., Waugh, S. M., Binkley, J., Hostomska, Z., Hostomský, Z., & Tuerk, C. (1995) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.0122 · Cited by 52 · see citing works

Free Energy Landscapes of RNA/RNA Complexes: With Applications to snRNA Complexes in Spliceosomes

Cao, S., & Chen, S. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.12.014 · Cited by 43 · see citing works

Coagulation Factor IXa as a Target for Treatment and Prophylaxis of Venous Thromboembolism

Eikelboom, J. W., Zelenkofske, S. L., & Rusconi, C. P. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.203117 · Cited by 38 · see citing works

ARC-1779, a PEGylated aptamer antagonist of von Willebrand factor for potential use as an anticoagulant or antithrombotic agent.

Cosmi, B. (2009) · PubMed · Cited by 31 · see citing works

Structural prediction and binding analysis of hybridized aptamers

Zhou, J., Soontornworajit, B., Snipes, M. P., & Wang, Y. (2010) · Journal of Molecular Recognition · doi:10.1002/jmr.1034 · Cited by 30 · see citing works

Stability, Specific Binding Activity, and Plasma Concentration in Mice of an Oligodeoxynucleotide Modified at 5'-Terminal with Poly (ethylene glycol).

Kawaguchi, T., ASAKAWA, H., TASHIRO, Y., Juni, K., & Sueishi, T. (1995) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.18.474 · Cited by 30 · see citing works

Chapter 8 Characterizing Ribonucleases In Vitro

Arraiano, C. M., Barbas, A., & Amblar, M. (2008) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(08)02208-8 · Cited by 18 · see citing works

A New Computational Approach for Mechanical Folding Kinetics of RNA Hairpins

Cao, S., & Chen, S. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2009.02.044 · Cited by 12 · see citing works

Folding Kinetics for the Conformational Switch between Alternative RNA Structures

Cao, S., Fürtig, B., Schwalbe, H., & Chen, S. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp107912s · Cited by 10 · see citing works

Smart nanoparticles for cancer therapy

Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073 · see citing works

Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression

Pi, F., Binzel, D. W., Lee, T. J., Li, Z., Sun, M., Rychahou, P. G., Li, H., Haque, F., Wang, S., Croce, C. M., et al. (2017) · Nature Nanotechnology · doi:10.1038/s41565-017-0012-z · Cited by 495 · see citing works

Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference–based bone anabolic strategy

Liang, C., Guo, B., Wu, H., Shao, N., Li, D., Liu, J., Dang, L., Wang, C., Li, H., Li, S., et al. (2015) · Nature Medicine · doi:10.1038/nm.3791 · Cited by 354 · see citing works

Advancement of the emerging field of RNA nanotechnology

Jasinski, D., Haque, F., Binzel, D. W., & Guo, P. (2017) · ACS Nano · doi:10.1021/acsnano.6b05737 · Cited by 352 · see citing works

Targeting signaling pathways in prostate cancer: mechanisms and clinical trials

He, Y., Xu, W., Xiao, Y., Huang, H., Gu, D., & Ren, S. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01042-7 · Cited by 275 · see citing works

Nucleic Acid Aptamers: An Emerging Tool for Biotechnology and Biomedical Sensing

Ku, T., Zhang, T., Luo, H., Yen, T., Chen, P., Han, Y., & Lo, Y. (2015) · Sensors · doi:10.3390/s150716281 · Cited by 242 · see citing works

Tumor cell-targeted delivery of CRISPR/Cas9 by aptamer-functionalized lipopolymer for therapeutic genome editing of VEGFA in osteosarcoma

Liang, C., Li, F., Wang, L., Zhang, Z., Wang, C., He, B., Li, J., Chen, Z., Shaikh, A. B., Liu, J., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.09.015 · Cited by 216 · see citing works

Development of Better Aptamers: Structured Library Approaches, Selection Methods, and Chemical Modifications

Brown, A., Brill, J., Amini, R., Nurmi, C., & Li, Y. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202318665 · Cited by 186 · see citing works

Methods and Applications of In Silico Aptamer Design and Modeling

Buglak, A. A., Samokhvalov, A. V., Zherdev, A. V., & Dzantiev, B. B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228420 · Cited by 157 · see citing works

Targeting Axl With an High-affinity Inhibitory Aptamer

Cerchia, L., Esposito, C. L., Camorani, S., Rienzo, A., Stasio, L., Insabato, L., Affuso, A., & de Franciscis, V. (2012) · Molecular Therapy · doi:10.1038/mt.2012.163 · Cited by 153 · see citing works

Artificial Intelligence in Aptamer–Target Binding Prediction

Chen, Z., Hu, L., Zhang, B., Lü, A., Wang, Y., Yu, Y., & Zhang, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073605 · Cited by 150 · see citing works

Advances in PSMA-targeted therapy for prostate cancer

Wang, F., Li, Z., Feng, X., Yang, D., & Lin, M. (2021) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-021-00394-5 · Cited by 147 · see citing works

An ultra-sensitive colorimetric detection of tetracyclines using the shortest aptamer with highly enhanced affinity

Kwon, Y. S., Raston, N. H. A., & Gu, M. B. (2013) · Chemical Communications · doi:10.1039/c3cc47108j · Cited by 120 · see citing works

Isolation and Optimization of Murine IL-10 Receptor Blocking Oligonucleotide Aptamers Using High-throughput Sequencing

Berezhnoy, A., Stewart, C. A., McNamara, J. O., Thiel, W. H., Giangrande, P. H., Trinchieri, G., & Gilboa, E. (2012) · Molecular Therapy · doi:10.1038/mt.2012.18 · Cited by 119 · see citing works

Rapid Identification of Cell-Specific, Internalizing RNA Aptamers with Bioinformatics Analyses of a Cell-Based Aptamer Selection

Thiel, W. H., Bair, T., Peek, A. S., Liu, X., Dassie, J. P., Stockdale, K. R., Behlke, M. A., Miller, F. J., & Giangrande, P. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043836 · Cited by 114 · see citing works

A comparative analysis of cell surface targeting aptamers

Kelly, L., Maier, K. E., Yan, A. C., & Levy, M. (2021) · Nature Communications · doi:10.1038/s41467-021-26463-w · Cited by 114 · see citing works

Specific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer by RNA Nanotechnology

Binzel, D. W., Shu, Y., Li, H., Sun, M., Zhang, Q., Shu, D., Guo, B., & Guo, P. (2016) · Molecular Therapy · doi:10.1038/mt.2016.85 · Cited by 111 · see citing works

Design and Prediction of Aptamers Assisted by In Silico Methods

Lee, S. J., Cho, J., Lee, B., Hwang, D., & Park, J.-W. (2023) · Biomedicines · doi:10.3390/biomedicines11020356 · Cited by 108 · see citing works

Targeted Inhibition of Prostate Cancer Metastases with an RNA Aptamer to Prostate-specific Membrane Antigen

Dassie, J. P., Hernandez, L. I., Thomas, G. S., Long, M. E., Rockey, W. M., Howell, C. A., Chen, Y., Hernández, F. J., Liu, X., Wilson, M. E., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.117 · Cited by 106 · see citing works

Current Progress on aptamer-targeted Oligonucleotide Therapeutics

Dassie, J. P., & Giangrande, P. H. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.118 · Cited by 102 · see citing works

Thermostability, Tunability, and Tenacity of RNA as Rubbery Anionic Polymeric Materials in Nanotechnology and Nanomedicine—Specific Cancer Targeting with Undetectable Toxicity

Binzel, D. W., Li, X., Burns, N., Khan, E., Lee, W.-J., Chen, L.-C., Ellipilli, S., Miles, W. O., Ho, Y. S., & Guo, P. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00009 · Cited by 97 · see citing works

Graphene and Other Nanomaterial-Based Electrochemical Aptasensors

Hernández, F. J., & Özalp, V. C. (2012) · Biosensors · doi:10.3390/bios2010001 · Cited by 96 · see citing works

Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies

Detchokul, S., Williams, E. D., Parker, M. W., & Frauman, A. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12260 · Cited by 95 · see citing works

Aptamer Cell-Based Selection: Overview and Advances

Catuogno, S., & Esposito, C. L. (2017) · Biomedicines · doi:10.3390/biomedicines5030049 · Cited by 89 · see citing works

Aptamer-conjugated PLGA nanoparticles for delivery and imaging of cancer therapeutic drugs

Hashemi, M., Shamshiri, A., Saeedi, M., Tayebi, L., & Robati, R. Y. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108485 · Cited by 86 · see citing works

Identifying high-affinity aptamer ligands with defined cross-reactivity using high-throughput guided systematic evolution of ligands by exponential enrichment

Levay, A. K., Brenneman, R., Hoinka, J., Sant, D., Cardone, M., Trinchieri, G., Przytycka, T. M., & Berezhnoy, A. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv534 · Cited by 84 · see citing works

Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy

Xu, C., Haque, F., Jasinski, D. L., Binzel, D. W., Shu, D., & Guo, P. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.09.043 · Cited by 74 · see citing works

Determination of minimal sequence for binding of an aptamer. A comparison of truncation and hybridization inhibition methods

Le, T. T., Chumphukam, O., & Cass, A. E. G. (2014) · RSC Advances · doi:10.1039/c4ra08243e · Cited by 71 · see citing works

Diagnosis of prostate cancer using anti-PSMA aptamer A10-3.2-oriented lipid nanobubbles

Fan, X., Guo, Y., Wang, L., Xiong, X., Zhu, L., & Fang, K. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s112951 · Cited by 70 · see citing works

Aptamer-conjugated mesoporous silica nanoparticles for simultaneous imaging and therapy of cancer

Vandghanooni, S., Barar, J., Eskandani, M., & Omidi, Y. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2019.115759 · Cited by 67 · see citing works

Could artificial intelligence revolutionize the development of nanovectors for gene therapy and mRNA vaccines?

Hasanzadeh, A., Hamblin, M. R., Kiani, J., Noori, H., Hardie, J. M., Karimi, M., & Shafiee, H. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101665 · Cited by 69 · see citing works

Structural basis of prostate-specific membrane antigen recognition by the A9g RNA aptamer

Ptáček, J., Zhang, D., Qiu, L., Kruspe, S., Motlova, L., Kolenko, P., Nováková, Z., Shubham, S., Havlínová, B., Baranová, P., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa494 · Cited by 65 · see citing works

Analyzing Secondary Structure Patterns in DNA Aptamers Identified via CompELS

Sullivan, R. S., Adams, M. C., Naik, R. R., & Milam, V. T. (2019) · Molecules · doi:10.3390/molecules24081572 · Cited by 65 · see citing works

Aptamer-conjugated multi-walled carbon nanotubes as a new targeted ultrasound contrast agent for the diagnosis of prostate cancer

Gu, F., Hu, C., Xia, Q., Gong, C., Shen, G., & Chen, Z. (2018) · Journal of Nanoparticle Research · doi:10.1007/s11051-018-4407-z · Cited by 60 · see citing works

Aptamers as Drug Delivery Vehicles

Kruspe, S., Mittelberger, F., Szameit, K., & Hahn, U. (2014) · ChemMedChem · doi:10.1002/cmdc.201402163 · Cited by 59 · see citing works

Targeted delivery of RNAi to cancer cells using RNA-ligand displaying exosome

Uddin, N., Binzel, D. W., Shu, D., Fu, T., & Guo, P. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.11.019 · Cited by 61 · see citing works

Using aptamers for targeted delivery of RNA therapies

Driscoll, J., Gondaliya, P., Zinn, D. A., Jain, R., Yan, I. K., Dong, H., & Patel, T. C. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.02.047 · Cited by 58 · see citing works

Label-free fluorescence detection of melamine with a truncated aptamer

Gu, C., Xiang, Y., Guo, H., & Shi, H. (2016) · The Analyst · doi:10.1039/c6an00537c · Cited by 56 · see citing works

In Silico Aptamer Docking Studies: From a Retrospective Validation to a Prospective Case Study'TIM3 Aptamers Binding

Rabal, O., Pastor, F., Villanueva, H., Soldevilla, M. M., Hervás‐Stubbs, S., & Oyarzábal, J. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2016.84 · Cited by 56 · see citing works

Discovery of Aptamer Ligands for Hepatic Stellate Cells Using SELEX

Chen, Z., Liu, H., Jain, A., Zhang, L., Liu, C., & Cheng, K. (2017) · Theranostics · doi:10.7150/thno.19374 · Cited by 56 · see citing works

Fluorometric determination of lipopolysaccharides via changes of the graphene oxide-enhanced fluorescence polarization caused by truncated aptamers

Ye, H., Duan, N., Gu, H., Wang, H., & Wang, Z. (2019) · Microchimica Acta · doi:10.1007/s00604-019-3261-8 · Cited by 56 · see citing works

Targeted siRNA delivery using aptamer‐siRNA chimeras and aptamer‐conjugated nanoparticles

Sivakumar, P., Kim, S., Kang, H. C., & Shim, M. S. (2018) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1543 · Cited by 52 · see citing works

An electrochemical dopamine aptasensor using the modified Au electrode with spindle-shaped gold nanostructure

Taheri, R. A., Eskandari, K., & Negahdary, M. (2018) · Microchemical Journal · doi:10.1016/j.microc.2018.08.008 · Cited by 50 · see citing works

Therapeutic aptamers in discovery, preclinical and clinical stages

Ismail, S. I., & Alshaer, W. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.08.006 · Cited by 50 · see citing works

Stepping Library-Based Post-SELEX Strategy Approaching to the Minimized Aptamer in SPR

He, X., Guo, L., He, J., Xu, H., & Xie, J. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b00700 · Cited by 49 · see citing works

Designing Anti-Influenza Aptamers: Novel Quantitative Structure Activity Relationship Approach Gives Insights into Aptamer – Virus Interaction

Musafia, B., Oren-Banaroya, R., & Noiman, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097696 · Cited by 49 · see citing works

Prediction of aptamer affinity using an artificial intelligence approach

Fallah, A., Havaei, S. A., Sedighian, H., Kachuei, R., & Fooladi, A. A. I. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb00909f · Cited by 42 · see citing works

Efficient HIV-1 inhibition by a 16 nt-long RNA aptamer designed by combining in vitro selection and in silico optimisation strategies

Sanchez-Luque, F. J., Stich, M., Manrubia, S. C., Briones, C., & Berzal‐Herranz, A. (2014) · Scientific Reports · doi:10.1038/srep06242 · Cited by 41 · see citing works

Enhancing DPYSL3 gene expression via a promoter-targeted small activating RNA approach suppresses cancer cell motility and metastasis

Li, C., Jiang, W., Hu, Q., Li, L., Dong, L., Chen, R., Zhang, Y., Tang, Y., Thrasher, J. B., Liu, C.-B., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8290 · Cited by 40 · see citing works

lncRNA in the liver: Prospects for fundamental research and therapy by RNA interference

Smekalova, E. M., Kotelevtsev, Y. V., Leboeuf, D., Shcherbinina, E. Y., Fefilova, A. S., Zatsepin, T. S., & Koteliansky, V. (2016) · Biochimie · doi:10.1016/j.biochi.2016.06.007 · Cited by 39 · see citing works

Strategies to bioengineer aptamer-driven nanovehicles as exceptional molecular tools for targeted therapeutics: A review

Thevendran, R., Sarah, S., Tang, T., & Citartan, M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.051 · Cited by 39 · see citing works

Enhanced growth inhibition of prostate cancer in vitro and in vivo by a recombinant adenovirus-mediated dual-aptamer modified drug delivery system

Jing, P., Cao, S., Xiao, S., Zhang, X., Ke, S., Ke, F., Yu, X., Wang, L., Wang, S., Luo, Y., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.10.003 · Cited by 37 · see citing works

Sensitive diagnosis of alpha-fetoprotein by a label free nanoaptasensor designed by modified Au electrode with spindle-shaped gold nanostructure

Heiat, M., & Negahdary, M. (2019) · Microchemical Journal · doi:10.1016/j.microc.2019.05.004 · Cited by 36 · see citing works

Methods for Evaluating Cell-Specific, Cell-Internalizing RNA Aptamers

Hernandez, L. I., Flenker, K. S., Hernández, F. J., Klingelhutz, A. J., McNamara, J. O., & Giangrande, P. H. (2013) · Pharmaceuticals · doi:10.3390/ph6030295 · Cited by 35 · see citing works

In vitro RNA SELEX for the generation of chemically-optimized therapeutic RNA drugs

Urak, K. T., Shore, S., Rockey, W. M., Chen, S., McCaffrey, A. P., & Giangrande, P. H. (2016) · Methods · doi:10.1016/j.ymeth.2016.03.003 · Cited by 33 · see citing works

Chemical modification improves the stability of the DNA aptamer GBI-10 and its affinity towards tenascin-C

Li, K., Deng, J., Jin, H., Yang, X., Fan, X., Li, L., Zhao, Y., Guan, Z., Wu, Y., Zhang, L., et al. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c6ob02577c · Cited by 32 · see citing works

Recent progress in the development of aptasensors for cancer diagnosis: Focusing on aptamers against cancer biomarkers

Vandghanooni, S., Sanaat, Z., Farahzadi, R., Eskandani, M., Omidian, H., & Omidi, Y. (2021) · Microchemical Journal · doi:10.1016/j.microc.2021.106640 · Cited by 32 · see citing works

Aptamer–siRNA Chimeras for HIV

Takahashi, M. M., Burnett, J., & Rossi, J. J. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-2432-5_11 · Cited by 31 · see citing works

Triggering RNAi with multifunctional RNA nanoparticles and their delivery

Dao, B. N., Viard, M., Martins, A. N., Kasprzak, W. K., Shapiro, B. A., & Afonin, K. A. (2015) · DNA and RNA Nanotechnology · doi:10.1515/rnan-2015-0001 · Cited by 30 · see citing works

Determination of minimal sequence for zearalenone aptamer by computational docking and application on an indirect competitive electrochemical aptasensor

Azri, F. A., Selamat, J., Sukor, R., Yusof, N. A., Raston, N. H. A., Eissa, S., Zourob, M. M., & Chinnappan, R. (2021) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-021-03336-1 · Cited by 30 · see citing works

Probing high-affinity 11-mer DNA aptamer against Lup an 1 (β-conglutin)

Nadal, P., Svobodová, M., Mairal, T., & O’Sullivan, C. K. (2013) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-013-7385-0 · Cited by 30 · see citing works

Improved Cancer Targeting by Multimerizing Aptamers on Nanoscaffolds

Omer, M., Andersen, V. L., Nielsen, J. S., Wengel, J., & Kjems, J. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.10.013 · Cited by 29 · see citing works

Metal-Labeled Aptamers as Novel Nanoprobes for Imaging Mass Cytometry Analysis

Yu, Y., Dang, J., Liu, X., Wang, L., Li, S., Zhang, T., & Ding, X. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.9b05159 · Cited by 27 · see citing works

Molecular bioengineering of functional nucleic acids

Du, Z., Wu, X., Dang, Y., Wu, Q., Fu, T., He, L., Wang, X., Mou, S., Fang, X., Qu, F., et al. (2025) · Nature Reviews Bioengineering · doi:10.1038/s44222-025-00361-y · Cited by 31 · see citing works

Structural computational modeling of RNA aptamers

Xu, X., Dickey, D. D., Chen, S., & Giangrande, P. H. (2016) · Methods · doi:10.1016/j.ymeth.2016.03.004 · Cited by 26 · see citing works

Development of Better Aptamers: Structured Library Approaches, Selection Methods, and Chemical Modifications

Brown, A., Brill, J., Amini, R., Nurmi, C., & Li, Y. (2024) · Angewandte Chemie · doi:10.1002/ange.202318665 · Cited by 25 · see citing works

In Vitro Selection and Characterization of DNA Aptamers to a Small Molecule Target

Ruscito, A., McConnell, E. M., Koudrina, A., Velu, R., Mattice, C., Hunt, V., McKeague, M., & DeRosa, M. C. (2017) · Current Protocols in Chemical Biology · doi:10.1002/cpch.28 · Cited by 25 · see citing works

Selection and Identification of Skeletal-Muscle-Targeted RNA Aptamers

Philippou, S., Mastroyiannopoulos, N. P., Makrides, N., Lederer, C. W., Kleanthous, M., & Phylactou, L. A. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.12.004 · Cited by 24 · see citing works

Combination of the PI3K Inhibitor ZSTK474 with a PSMA-Targeted Immunotoxin Accelerates Apoptosis and Regression of Prostate Cancer

Baiz, D., Hassan, S., Choi, Y. A., Flores, A., Karpova, Y., Yancey, D., Pullikuth, A., Sui, G., Sadelain, M., Debinski, W., et al. (2013) · Neoplasia · doi:10.1593/neo.13986 · Cited by 24 · see citing works

De novo ssRNA Aptamers against the SARS-CoV-2 Main Protease: In Silico Design and Molecular Dynamics Simulation

Morena, F., Argentati, C., Tortorella, I., Emiliani, C., & Martino, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136874 · Cited by 23 · see citing works

Developing slow-off dickkopf-1 aptamers for early-diagnosis of hepatocellular carcinoma

Zhou, Y., Li, W., Tseng, Y., Zhang, J., & Liu, J. (2018) · Talanta · doi:10.1016/j.talanta.2018.10.014 · Cited by 23 · see citing works

A highly sensitive SERS aptasensor using a novel truncated aptamer for the detection of Deoxynivalenol

Han, X., Qin, M., Lü, X., Wang, Q., Zhang, Y., & Wang, Z. (2024) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2024.136908 · Cited by 21 · see citing works

Structural properties and binding mechanism of DNA aptamers sensing saliva melatonin for diagnosis and monitoring of circadian clock and sleep disorders

Pundir, M., Rosa, M. C. D., Lobanova, L., Abdulmawjood, S., Chen, D., Papagerakis, S. M., & Papagerakis, P. (2023) · Analytica Chimica Acta · doi:10.1016/j.aca.2023.340971 · Cited by 19 · see citing works

Revealing Nucleic Acid Mutations Using Förster Resonance Energy Transfer-Based Probes

Junager, N., Kongsted, J., & Astakhova, K. (2016) · Sensors · doi:10.3390/s16081173 · Cited by 19 · see citing works

Suppression of Prostate Cancer Metastasis by DPYSL3-Targeted saRNA

Li, B., & Li, C. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-4310-9_15 · Cited by 19 · see citing works

Synthesis of Isolated DNA Aptamer and Its Application of AC-Electrothermal Flow-Based Rapid Biosensor for the Detection of Dengue Virus in a Spiked Sample

Park, H., Lee, H., Lee, M., Baek, C., Park, J. A., Jang, M., Kwon, Y., Min, J., & Lee, T. (2023) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.3c00249 · Cited by 18 · see citing works

A comprehensive investigation of the biophysical approach for aptamer functionalized nanoparticles in cancer therapy: a review

Navaneeth, A. G., & Karthikeyan, S. (2024) · RSC Pharmaceutics · doi:10.1039/d3pm00027c · Cited by 17 · see citing works

The Diagnostic Potential of RNA Aptamers against the NS1 Protein of Dengue Virus Serotype 2

Thevendran, R., Rogini, S., Leighton, G., Mutombwera, A., Shigdar, S. L., Tang, T., & Citartan, M. (2023) · Biology · doi:10.3390/biology12050722 · Cited by 17 · see citing works

Prostate-Specific Membrane Antigen-Targeted NIR Phototheranostics for Prostate Cancer

Solanki, K., Ahmed, N., Srivastava, N., & Meher, N. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.4c00819 · Cited by 17 · see citing works

A Theranostic “SMART” Aptamer for Targeted Therapy of Prostate Cancer

de Franciscis, V. (2014) · Molecular Therapy · doi:10.1038/mt.2014.190 · Cited by 17 · see citing works

Improved Synthesis and In Vitro Evaluation of an Aptamer Ribosomal Toxin Conjugate

Kelly, L., Kratschmer, C., Maier, K. E., Yan, A. C., & Levy, M. (2016) · Nucleic Acid Therapeutics · doi:10.1089/nat.2015.0599 · Cited by 16 · see citing works

Characterization of A Bifunctional Synthetic RNA Aptamer and A Truncated Form for Ability to Inhibit Growth of Non-Small Cell Lung Cancer

Wang, H., Qin, M., Liu, R., Ding, X., Chen, I. S. Y., & Jiang, Y. (2019) · Scientific Reports · doi:10.1038/s41598-019-55280-x · Cited by 16 · see citing works

Bioinformatics Algorithms for Molecular Docking: IT and Chemistry Synergy

Rodriguez, M., Tejani, J. G., Pydipalli, R., & Patel, B. (2018) · Asia Pacific Journal of Energy and Environment · doi:10.18034/apjee.v5i2.742 · Cited by 16 · see citing works

Nanotechnology Meets the Tumor Microenvironment: Unlocking New Horizons in Cancer Therapy

Yadav, P., Yadav, A. K., & Bhatia, D. D. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c01120 · Cited by 16 · see citing works

Competition-Enhanced Ligand Selection to Identify DNA Aptamers

Tapp, M., Slocik, J. M., Dennis, P. B., Naik, R. R., & Milam, V. T. (2018) · ACS Combinatorial Science · doi:10.1021/acscombsci.8b00048 · Cited by 15 · see citing works

Optimization of Short RNA Aptamers for TNBC Cell Targeting

Camorani, S., d’Argenio, A., Agnello, L., Nilo, R., Zannetti, A., Ibarra, L. E., Fedele, M., & Cerchia, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073511 · Cited by 15 · see citing works

Aptamers and apple pies: a mini-review of PSMA aptamers and lessons from Donald S. Coffey.

Lupold, S. E. (2018) · Europe PMC (PubMed Central) · Cited by 15 · see citing works

ΔPSap4#5 surface-functionalized abiraterone-loaded nanoparticle successfully inhibits carcinogen-induced prostate cancer in mice: a mechanistic investigation

Hoque, A. A., Dutta, D., Paul, B., Kumari, L., Ehsan, I., Dhara, M., Mukherjee, B., Quadir, M., Kaipparettu, B. A., Laha, S., et al. (2023) · Cancer Nanotechnology · doi:10.1186/s12645-023-00223-5 · Cited by 14 · see citing works

Thermodynamic and first-principles biomolecular simulations applied to synthetic biology: promoter and aptamer designs

Presnell, K. V., & Alper, H. S. (2017) · Molecular Systems Design & Engineering · doi:10.1039/c7me00083a · Cited by 14 · see citing works

Characterization of DNA aptamer–protein binding using fluorescence anisotropy assays in low-volume, high-efficiency plates

Weaver, S. D., & Whelan, R. J. (2021) · Analytical Methods · doi:10.1039/d0ay02256j · Cited by 13 · see citing works

Metamorphosis of prostate specific membrane antigen (PSMA) inhibitors

Nikfarjam, Z., Zargari, F., Nowroozi, A., & Bavi, O. (2022) · Biophysical Reviews · doi:10.1007/s12551-021-00919-1 · Cited by 12 · see citing works

Selection and characterization of bispecific aptamers against malachite green and leucomalachite green

Wu, W., Sun, Q., Li, T., Liu, K., Jiang, Y. L., Wang, Y., & Yang, Y. (2022) · Analytical Biochemistry · doi:10.1016/j.ab.2022.114849 · Cited by 12 · see citing works

Prediction of shorter oligonucleotide sequences recognizing aflatoxin M1

Pandey, A. K., Rajput, Y. S., Singh, D., & Sharma, R. (2017) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1586 · Cited by 11 · see citing works

Nucleic acid aptamers in orthopedic diseases: promising therapeutic agents for bone disorders

He, Z., Peng, Q., Bin, W., Zhao, L., Chen, Y., Zhang, Y., Yang, W., Yan, X., & Liu, H. (2025) · Bone Research · doi:10.1038/s41413-025-00447-8 · Cited by 10 · see citing works

Identification of novel aptamers targeting cathepsin B-overexpressing prostate cancer cells

Pereira, A. C., Pina, A. F., Sousa, D. A., Ferreira, D., Pereira, A. C., Rodrigues, J. L., Melo, L. D. R., Sales, M. G. F., Sousa, S. F., & Rodrigues, L. R. (2022) · Molecular Systems Design & Engineering · doi:10.1039/d2me00022a · Cited by 10 · see citing works

Nucleic Acid Aptamers for Biomaterials Development

Battig, M. R., & Wang, Y. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-396983-5.00018-1 · Cited by 10 · see citing works

Manipulating the in vivo immune response by targeted gene knockdown

Lieberman, J. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.06.005 · Cited by 9 · see citing works

Generation of an RNA aptamer against LipL32 of Leptospira isolated by Tripartite-hybrid SELEX coupled with in-house Python-aided unbiased data sorting

Yeoh, T. S., Hamdani, H. Y., Bukari, B. A., Tang, T., & Citartan, M. (2023) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2023.117186 · Cited by 8 · see citing works

A Truncated Multi-Thiol Aptamer-Based SARS-CoV-2 Electrochemical Biosensor: Towards Variant-Specific Point-of-Care Detection with Optimized Fabrication

Ramirez, S. R. M., Samiseresht, N., Martínez-Roque, M. A., Catania, F., Graef, K., Rabe, M., Offenhäusser, A., Mayer, D., & Miranda, G. F. (2025) · Biosensors · doi:10.3390/bios15010024 · Cited by 7 · see citing works

RNA aptamer-mediated gene therapy of prostate cancer: lessons from the past and future directions

Arese, M., Mahmoudian, M., & Bussolino, F. (2023) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2292691 · Cited by 7 · see citing works

Original Articles Rational Truncation of an RNA Aptamer to Prostate-Specific Membrane Antigen Using Computational Structural Modeling

Zou, X., Chen, S.-J., & Giangr, P. H. (2015)

Structural computational modeling of RNA aptamers

Xu, X., Dickey, D. D., Chen, S., & Giangrande, P. H. (2016) · Methods · doi:10.1016/j.ymeth.2016.03.004 · Cited by 26 · see citing works

Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen.

Lupold, S. E., Hicke, B. J., Lin, Y. H., & Coffey, D. S. (2002) · PubMed · Cited by 564 · see citing works

Structural basis of prostate-specific membrane antigen recognition by the A9g RNA aptamer

Ptáček, J., Zhang, D., Qiu, L., Kruspe, S., Motlova, L., Kolenko, P., Nováková, Z., Shubham, S., Havlínová, B., Baranová, P., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa494 · Cited by 65 · see citing works

Optimization of Short RNA Aptamers for TNBC Cell Targeting

Camorani, S., d’Argenio, A., Agnello, L., Nilo, R., Zannetti, A., Ibarra, L. E., Fedele, M., & Cerchia, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073511 · Cited by 15 · see citing works